Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Palbociclib (Ibrance) in Combination with Irinotecan and Temozolomide in Pediatric Patients with Recurrent or Refractory Solid Tumors
Grant
Overview
Affiliation
Overview
Awarded By
PUBLIC HEALTH INSTITUTE (PHI)
Total Award Amount
157302.00
Direct Costs
121001.00
Sponsor Award Id
Affiliation
Contributor
Elizabeth Alva
Investigator
Emily Johnston
Investigator
Girish Dhall
Investigator
Gregory Friedman M.D.
Principal Investigator
Jamie Aye
Investigator
Kimberly Whelan M.D.
Investigator
Laura Metrock
Investigator